AP3343A - Pyrazole compounds as CRTH2 antagonists - Google Patents

Pyrazole compounds as CRTH2 antagonists

Info

Publication number
AP3343A
AP3343A AP2013006942A AP2013006942A AP3343A AP 3343 A AP3343 A AP 3343A AP 2013006942 A AP2013006942 A AP 2013006942A AP 2013006942 A AP2013006942 A AP 2013006942A AP 3343 A AP3343 A AP 3343A
Authority
AP
ARIPO
Prior art keywords
pyrazole compounds
crth2 antagonists
crth2
antagonists
pyrazole
Prior art date
Application number
AP2013006942A
Other languages
English (en)
Other versions
AP2013006942A0 (en
Inventor
Thorsten Oost
Ralf Anderskewitz
Wolfgang Rist
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43799503&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP3343(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of AP2013006942A0 publication Critical patent/AP2013006942A0/xx
Application granted granted Critical
Publication of AP3343A publication Critical patent/AP3343A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AP2013006942A 2011-01-24 2012-01-20 Pyrazole compounds as CRTH2 antagonists AP3343A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11151876 2011-01-24
PCT/EP2012/050830 WO2012101043A1 (en) 2011-01-24 2012-01-20 Pyrazole compounds as crth2 antagonists

Publications (2)

Publication Number Publication Date
AP2013006942A0 AP2013006942A0 (en) 2013-06-30
AP3343A true AP3343A (en) 2015-07-31

Family

ID=43799503

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2013006942A AP3343A (en) 2011-01-24 2012-01-20 Pyrazole compounds as CRTH2 antagonists

Country Status (35)

Country Link
US (1) US8759386B2 (pl)
EP (1) EP2668181B1 (pl)
JP (1) JP5695216B2 (pl)
KR (2) KR101923365B1 (pl)
CN (4) CN103339125B (pl)
AP (1) AP3343A (pl)
AR (1) AR084916A1 (pl)
AU (1) AU2012210718B2 (pl)
BR (1) BR112013017570B1 (pl)
CA (1) CA2825458C (pl)
CL (1) CL2013001945A1 (pl)
CO (1) CO6801731A2 (pl)
CY (1) CY1116012T1 (pl)
DK (1) DK2668181T3 (pl)
EA (1) EA022559B1 (pl)
EC (1) ECSP13012832A (pl)
ES (1) ES2529452T3 (pl)
GE (1) GEP20156332B (pl)
HR (1) HRP20150069T1 (pl)
IL (1) IL226920A (pl)
MA (1) MA34838B1 (pl)
MX (1) MX342830B (pl)
MY (1) MY163012A (pl)
PE (1) PE20140860A1 (pl)
PH (2) PH12013501356A1 (pl)
PL (1) PL2668181T3 (pl)
PT (1) PT2668181E (pl)
RS (1) RS53785B1 (pl)
SG (1) SG192096A1 (pl)
SI (1) SI2668181T1 (pl)
TN (1) TN2013000280A1 (pl)
TW (1) TWI527809B (pl)
UA (1) UA109696C2 (pl)
UY (1) UY33873A (pl)
WO (1) WO2012101043A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8759386B2 (en) * 2011-01-24 2014-06-24 Boehringer Ingelheim International Gmbh Pyrazole compounds as CRTH2 antagonists
JP5999387B2 (ja) * 2011-03-25 2016-09-28 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Crth2拮抗薬としてのピラゾール化合物
WO2014079805A1 (en) * 2012-11-23 2014-05-30 Boehringer Ingelheim International Gmbh Pyrazole compounds for treating hairloss
US20140148492A1 (en) * 2012-11-23 2014-05-29 Boehringer Ingelheim International Gmbh Bicyclosubstituted pyrazole compounds for treating hair loss
EA202092275A1 (ru) * 2018-03-23 2021-02-09 Палатин Текнолоджиз, Инк. Составы пептидов, специфичных к рецептору меланокортина, и способы доставки в желудочно-кишечный тракт
ES2974634T3 (es) 2018-12-21 2024-06-28 Celgene Corp Inhibidores de tienopiridinas de RIPK2
TWI898700B (zh) * 2023-07-03 2025-09-21 南韓商因諾沃治療有限公司 新穎吡唑衍生物及其使用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010057118A2 (en) * 2008-11-17 2010-05-20 Amira Pharmaceuticals, Inc. Heterocyclic antagonists of prostaglandin d2 receptors

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260322A (en) 1990-10-08 1993-11-09 Merck & Co., Inc. Angiotension II antagonists in the treatment of hyperuricemia
CA2390923A1 (en) * 1999-11-10 2001-05-31 Takeda Chemical Industries, Ltd. 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity
DE60303238T2 (de) 2003-04-25 2006-09-14 Actimis Pharmaceuticals, Inc., La Jolla Pyrimidin-Essigsäure Derivate geeignet zur Behandlung von CRTH2-bedingten Krankheiten
EP1675832B1 (en) * 2003-10-24 2008-02-20 Glaxo Group Limited Heterocyclyl compounds
EP1838690A2 (en) * 2004-12-21 2007-10-03 Devgen N.V. Compounds with kv4 ion channel activity
JP4950542B2 (ja) * 2006-04-07 2012-06-13 岩手東芝エレクトロニクス株式会社 固体撮像装置およびその製造方法
EP2040700B1 (en) 2006-06-06 2010-11-24 Glaxo Group Limited N- (phenylmethyl) -2- (1h-pyraz0l-4-yl) acetamide derivatives as p2x7 antagonists for the treatment of pain, inflammation and neurodegeneration
JP4469924B2 (ja) * 2006-11-27 2010-06-02 ファイザー・プロダクツ・インク ピラゾール類似体
EP2205569B1 (en) 2007-09-25 2012-02-29 Actimis Pharmaceuticals, Inc., Alkylthio pyrimidines as crth2 antagonists
KR20100061746A (ko) * 2007-09-25 2010-06-08 액티미스 파마수티컬스 인코포레이티드 Crth2 길항제로서의 2-s-벤질 치환된 피리미딘
JP2011088826A (ja) * 2008-01-31 2011-05-06 Astellas Pharma Inc 芳香族カルボン酸化合物
MX2010014172A (es) * 2008-07-03 2011-02-22 Amira Pharmaceuticals Inc Antagonistas de receptores de prostaglandina d2.
GB2463788B (en) * 2008-09-29 2010-12-15 Amira Pharmaceuticals Inc Heteroaryl antagonists of prostaglandin D2 receptors
JP2012517405A (ja) * 2009-02-09 2012-08-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 呼吸器及び胃腸の疾患の治療のための新規医薬組成物
ES2545865T3 (es) * 2010-01-27 2015-09-16 Boehringer Ingelheim International Gmbh Compuestos de pirazol como antagonistas de CRTH2
JP2013535457A (ja) * 2010-07-28 2013-09-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 呼吸器系及び炎症性疾患の治療用医薬組成物
US8759386B2 (en) * 2011-01-24 2014-06-24 Boehringer Ingelheim International Gmbh Pyrazole compounds as CRTH2 antagonists

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010057118A2 (en) * 2008-11-17 2010-05-20 Amira Pharmaceuticals, Inc. Heterocyclic antagonists of prostaglandin d2 receptors

Also Published As

Publication number Publication date
CL2013001945A1 (es) 2013-10-25
PH12018501531A1 (en) 2019-04-08
KR102251939B1 (ko) 2021-05-14
US20130023576A1 (en) 2013-01-24
UY33873A (es) 2012-07-31
ES2529452T3 (es) 2015-02-20
IL226920A (en) 2016-11-30
TN2013000280A1 (en) 2014-11-10
CY1116012T1 (el) 2017-01-25
MA34838B1 (fr) 2014-01-02
CA2825458C (en) 2021-01-26
CN103339125A (zh) 2013-10-02
JP5695216B2 (ja) 2015-04-01
KR20140005931A (ko) 2014-01-15
JP2014502986A (ja) 2014-02-06
TW201245184A (en) 2012-11-16
CN107011332B (zh) 2020-03-13
HK1210467A1 (en) 2016-04-22
HK1186183A1 (en) 2014-03-07
PE20140860A1 (es) 2014-07-20
PH12013501356A1 (en) 2013-09-02
EP2668181A1 (en) 2013-12-04
CN104628705B (zh) 2017-04-12
KR101923365B1 (ko) 2018-11-30
CA2825458A1 (en) 2012-08-02
GEP20156332B (en) 2015-07-27
EP2668181B1 (en) 2014-11-05
WO2012101043A1 (en) 2012-08-02
HRP20150069T1 (hr) 2015-02-27
AR084916A1 (es) 2013-07-10
KR20180129962A (ko) 2018-12-05
BR112013017570A2 (pt) 2016-10-18
MX342830B (es) 2016-10-14
CN104961732A (zh) 2015-10-07
AU2012210718A1 (en) 2013-07-04
SI2668181T1 (sl) 2015-02-27
PT2668181E (pt) 2015-02-05
AP2013006942A0 (en) 2013-06-30
SG192096A1 (en) 2013-08-30
MX2013008082A (es) 2013-09-13
HK1215247A1 (zh) 2016-08-19
MY163012A (en) 2017-07-31
AU2012210718B2 (en) 2016-06-02
EA022559B1 (ru) 2016-01-29
CN104961732B (zh) 2017-07-11
TWI527809B (zh) 2016-04-01
DK2668181T3 (da) 2015-01-19
CN103339125B (zh) 2015-07-15
CN107011332A (zh) 2017-08-04
ECSP13012832A (es) 2013-09-30
CO6801731A2 (es) 2013-11-29
EA201300857A1 (ru) 2013-12-30
US8759386B2 (en) 2014-06-24
NZ611695A (en) 2015-04-24
UA109696C2 (xx) 2015-09-25
BR112013017570B1 (pt) 2022-01-11
RS53785B1 (sr) 2015-06-30
CN104628705A (zh) 2015-05-20
PL2668181T3 (pl) 2015-04-30

Similar Documents

Publication Publication Date Title
IL286152A (en) Modified imidazopyridinyl-aminopyridine compounds
AP3360A (en) Pyrazole compounds as CRTH2 antagonists
AP3391A (en) 2-Amino-4-arylthiazole compounds as TROA1 antagonists
EP2698368A4 (en) NEW PYRAZOLE DERIVATIVE
PT2710018T (pt) Compostos macrocíclicos como inibidores de proteína quinases
GB201118652D0 (en) New compounds
GB201118654D0 (en) New compounds
LT2776436T (lt) Naujieji junginiai
EP2709609A4 (en) HETEROCYCLIC COMPOUNDS
ZA201308939B (en) Pyrazole derivatives
GB201106814D0 (en) New compounds
IL226920A (en) Pyrazole compounds as antagonists of crth2
EP2771012A4 (en) NEW CONNECTIONS
ZA201303800B (en) Pyrazole compounds
GB201119590D0 (en) New compounds I
GB201101821D0 (en) Novel heterocyclic compounds 1
GB201101822D0 (en) Novel heterocyclic compounds 2
GB201101823D0 (en) Novel heterocyclic compounds 4
GB201102024D0 (en) Novel heterocyclic compounds 3
GB201106262D0 (en) Compounds
GB201105511D0 (en) Compounds
GB201105531D0 (en) Compounds
GB201114195D0 (en) Compounds
GB201119745D0 (en) Compounds
GB201103298D0 (en) Liqwate wallpaper